Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
Abstract Background Cardiovascular-kidney-metabolic (CKM) syndrome and systemic inflammation significantly contribute to mortality. However, the joint associations of CKM stages and systemic inflammation with all-cause and cardiovascular disease (CVD) mortality remain unclear. This study aimed to ev...
Saved in:
Main Authors: | Yifei Cao, Wenfeng Wang, Shidong Xie, Yanfang Xu, Zishan Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-024-21131-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
by: Katharine Barnard-Kelly, et al.
Published: (2025-02-01) -
Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
by: M R Essop, et al.
Published: (2023-11-01) -
Association of tea consumption with all-cause/cardiovascular disease mortality in the chronic kidney disease population: an assessment of participation in the national cohort
by: Jin Li, et al.
Published: (2025-12-01) -
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study
by: Yaohua Hu, et al.
Published: (2025-01-01) -
Association of live microbes intake and risk of all-cause, cardiovascular disease, and cancer-related mortality in patients with chronic kidney disease
by: Debin Chen, et al.
Published: (2025-12-01)